Marianne Lohr

Title: The Innovations of Marianne Lohr

Introduction

Marianne Lohr is a notable inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the area of angiogenesis inhibition. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to advancing science.

Latest Patents

Marianne Lohr holds a patent for "VEGF peptides and their use for inhibiting angiogenesis." This patent describes a peptide that includes part or all of the amino acid sequence QKRKRKKSRYKSWSVP, which is derived from Vascular Endothelial Growth Factor (VEGF). This peptide has demonstrated the ability to inhibit angiogenesis, a process that is crucial in various diseases, including cancer.

Career Highlights

Throughout her career, Marianne has focused on developing therapeutic solutions that address critical health challenges. Her work at Ark Therapeutics Limited has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Marianne has worked alongside esteemed colleagues such as David Lawrence Selwood and Ian Zachary. These collaborations have enriched her research and expanded the impact of her innovations.

Conclusion

Marianne Lohr's contributions to the field of biotechnology, particularly through her patent on VEGF peptides, highlight her role as a pioneering inventor. Her work continues to inspire advancements in medical science and therapeutic development.